Coexisting Causes of Ischemic Stroke
Arch Neurol 57:1139-1144,1113, Moncayo,J. et al, 2000
Serotonin Sydrome
Medicine 79:201-209, Mason,P.J. et al, 2000
Valproate, Hyperandrogenism, and Polycystic Ovaries
Arch Neurol 57:1064-1068, Isojarvi,J.I.T. & Tapanainen,J.S., 2000
Thienopyridines or Aspirin to Prevent Stroke and Other Serious Vascular Events in patients at High Risk of Vascular Disease?
Stroke 31:1779-1784, Hankey,G.J. et al, 2000
Visual Impairment in Children with Epilepsy Treated with Vigabatrin
Ann Neurol 48:60-64, Gross-Tsur,V. et al, 2000
Stroke, a Major and Increasing Risk Factor for Femoral Neck Fracture
Stroke 31:1572-1577, Ramnemark,A. et al, 2000
Low-Molecular-Weight heparins and Heparinoids in Acute ischemic Stroke
Stroke 31:1770-1778, Bath,P.M.W. et al, 2000
Perioperative and Late Stroke Rates of Carotid Endarterectomy Contralateral to Carotid Artery Occlusion
Stroke 31:1566-1571, AbuRahma,A.F. et al, 2000
Hypothermia and Thermoregulatory Derangements Induced by Valproic Acid
Neurol 55:150-151, Zachariah,S.B. et al, 2000
Visual Function Loss From Vigabatrin
Neurol 55:40-45, Johnson,M.A. et al, 2000
Prospective Cohort Study to Determine if Trial Efficacy of Anticoagulation for Stroke Prevention in Atrial Fibrillation Translates Into Clinical Effectiveness
BMJ 320 :1236-1239,1219, Kalra,L.,et al, 2000
Atrial Fibrilation and the Risk of Cerebral White Matter Lesions
Neurol 54:1795-1801, de Leeuw,F.E.,et al, 2000
Pyridostigmine-Induced Microcephaly
Neurol 54:1873-1874, Niesen,C.E.&Shah,N.S., 2000
Osteoporosis in Neurological Disorders
JNNP 68:543-549, Lloyd,M.E.,et al, 2000
Measles,MMR, and Autism: The Confusion Continues
Lancet 355:1379, , 2000
Epilepsy in Elderly People
Lancet 355:1441-1446, Stephen,L.J.&Brodie,M.J., 2000
Deterioration of Giant Cell Arteritis With Corticosteroid Therapy
Arch Neurol 57:581-584, Staunton,H.,et al, 2000
Effect of Eliminating Compensation for Pain and Suffering on the Outcome of Insurance Claims for Whiplash Injury
NEJM 342:11790-1186,1211, Cassidy,J.D.,et al, 2000
Low Molecular-Weight Heparin Versus Aspirin in Patients With Acute Ischaemic Stroke and Atrial Fibrillation: A Double-Blind Randomised Study
Lancet 355:1205-1210, Berge,E.,et al, 2000
Therapeutic Dilemma
Neurol 54:1404-1407, Romanelli,F.,et al, 2000
Adverse Effect of Anticonvulsants on Efficacy of Chemotherapy for Acute Lymphoblastic Leukaemia
Lancet 356:285-290, Relling,M.V. et al, 2000
Management of Epilepsy in Adolescents and Adults
Lancet 356:323-329, Brodie,M.J. & French,J.A., 2000
Levetiracetam for Partial Seizures: Results of A Double-Blind, Randomized Clinical Trial
Neurol 55:236-242, Cereghino,J.J. et al, 2000
Intracranial Vertebrobasilar Stenosis: Angioplasty and Follow-Up
AJNR 21:1293-1301, Nahser,H.C. et al, 2000
Reversible Tacrolimus-Induced Neurotoxicity Isolated to the Brain Stem
AJNR 21:1251-1254, Oliverio,P.J. et al, 2000
Retrospective Analysis of the Use of Cyclosporine in Myasthenia Gravis
Neurol 55:448-450, Ciafaloni,E. et al, 2000
Two New Drugs for Epilepsy
The Medical Letter, 42:33-35, , 2000
Arteriovenous Bubbles Following Cold Water Sport Dives: Relation to Right-to-left Shunting
Neurol 55:1741-1743, Gerriets,T.,et al, 2000
Association of Primary Central Nervous System Lymphoma with Long-Term Azathioprine Therapy for Myasthenia Gravis?
Ann Neurol 47: 682-683, Herrlinger,U.,et al, 2000
Amusement park stroke
Neurol 55:564, Burneo, J.G.,et al, 2000
The Central Nervous system and Infection by Candida Species
Diagn Microbial Infect Dis 37:169-179, Sanchez-Portocarrero, J.,et al, 2000
Evaluation of Metronidazole Toxicity: A Prospective Study
Int J Clin Pharmacol Res 19:83-88, Kapoor,K.,et al, 1999
Bilateral Basal Ganglial Necrosis After Allogeneic Bone Marrow Transplantation in a Child with Kostmann Syndrome
Bone Marrow Transplantation 23:515-517, Suga,N.,et al, 1999
Severe Akinetic Syndrome Resulting From a Bilateral Basal Ganglia Lesion Following Bone Marrow Transplantation
Movement Disorders 14:525-528, Pirker,W.,et al, 1999
Diffusion-Weighted MR Imaging of Global Cerebral Anoxia
AJNR 20:999-1007, Arbelaez,A.,et al, 1999
Oxcarbazepine: Double-blind, Randomized, Placebo-control, Monotherapy Trial for Partial Seizures
Neurol 52:732-737, Schachter,S.C. et al, 1999
Bilateral Posterior Ischemic Optic Neuropathy After Spinal Surery
Am J Ophthal 127:354-355, Alexandrakis,G.&Lam,B.L., 1999
Efficient Operation of a High-Volume Anticoagulation Clinic
Am J Health Syst Pharm 56:443-449, Foss,M.T.,et al, 1999
Reye's Syndrome in the United States from 1981 Through 1997
NEJM 340:1377-1382,1423, Belay,E.D.,et al, 1999
Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999
Neurologic Complications of Pediatric Lung Transplantation
Neurol 53:1542-1549, Wong,M.,et al, 1999
Visual Field Defects Associated with Vigabatrin Therapy
JNNP 67:716-722, Lawden,M.C.,et al, 1999
Gabapentin-Induced Anorgasmia
Neurol 53:2209, Clark,J.D.&Elliott,J., 1999
Sudden Unexpected Death in epilepsy (SUDEP): A Clinical Perspective and a Search for Risk Factors
JNNP 67:439-444,427, Kloster,R.&Engelskjon,T., 1999
Psychiatric Adverse Events During Vigabatrin Therapy
Neurol 53:1503-1511, Levinson,D.F.&Devinsky,O., 1999
Long-Term Treatment with Vagus Nerve Stimulation in Patients with Refractory Epilepsy
Neurol 53:1731-1735, Morris,G.L.,et al, 1999
The Intensive Care Management of Acute Ischemic Stroke
The Neurologist 5:313-325, Deibert,E.&Diringer,M.N., 1999
Intra-Arterial Prourokinase for Acute Ischemic Stroke, The PROACT II Study:A Randomized Controlled Trial
JAMA 282:2003-2011, Furlan,A.,et al, 1999
Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999
Clinicopath Conf,Thrombosis of St. Jude Medical Aortic Valve,Intra-Cerebral Lobar Hemorrhage, Case 37-1999
NEJM 341:1829-1835, , 1999